PRECISION BIOSCIENCES INC — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Naresh Tanna was promoted to Senior Vice President, Chief Financial Officer effective August 1, 2026, with a base salary of $400,000, target bonus of 40% of base salary, and severance protections. In a termination without cause or good reason, he receives 12 months base salary plus 1x target bonus and COBRA subsidy; in a change-of-control scenario within 12 months of a transaction, he receives 18 months base salary plus 1.5x target bonus. The company also adopted a Non-Employee Director Compensation Program effective September 15, 2026, with annual board fees ranging from $40,000 (non-chair members) to $72,500 (chair), plus committee fees and equity grants up to $750,000 annually in total compensation.
Why this rating
CFO promotion and employment terms are routine for a public company of this size. Severance protections represent modest costs (~$533K max annual exposure pre-CIC, ~$1M post-CIC) relative to $47M market cap. Director compensation program is standard administrative practice.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.